Complete Genomics, Inc. (GNOM) Tops Q2 Views on Top and Bottom

Complete Genomics, Inc. (NASDAQ: GNOM) reported Q2 EPS of ($0.55), $0.03 better than the analyst estimate of ($0.58). Revenue for the quarter came in at $8.7 million versus the consensus estimate of $7.72 million.

For earnings history and earnings-related data on Complete Genomics, Inc. (GNOM) click here.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Nomura/Instinet Upgrades Genting Singapore (GENS:SP) (GIGNY) to Neutral
• Boston Omaha Corporation (BOC) Misses Q2 EPS by 2c
• zSpace, Inc. (ZSPC) Reports Q2 results